Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Finasteride helps hair loss patients' quality of life.

Finasteride slows down motherly behavior in first-time pregnant rats.

Homeopathic and biochemic treatments led to hair regrowth and improved confidence in a man with hair loss.

Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Hair and scalp health needs more attention in medical training.

Motion-graphic videos improve patient understanding more than verbal explanations for platelet-rich plasma therapy.

Holistic treatment improved hair growth, reduced hair loss, and boosted well-being.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Adults can develop late-onset loose anagen syndrome, which may often be misdiagnosed.

QR678 Neo® improves hair transplant success and hair regrowth.

Higher cortisol and cortisone levels in hair may predict mood disorders after a stroke.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

Male pattern baldness doesn't significantly affect mental health or sexual well-being.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Hair loss negatively impacts quality of life, and psychological support can help.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.